CRISPR Therapeutics having a good day, gaining 8.89%
Markets are currently flat. Nasdaq holds at 11,500. S&P 500 trades sideways at 3,996.46.
Today's muted price action is occurring amid mixed market indicators – United States Existing Home Sales (Jan) came out at 4 million, while a consensus of analysts was expecting 4 million.
Assets that recorded the greatest percentage change in relation to their peers are designated as "Top Movers" with the most active healthcare stocks listed below.
CRISPR Therapeutics leaps up 8.89% after trading as low as $47.41
After closing the previous trading day at $46.63, CRISPR Therapeutics is up to $50.78, which makes for a move of 8.89%/$4.15 today. The company has a market cap of $3.98 billion with an average daily trading volume of 1 million shares. So far this year, it has been beating the Nasdaq by 4.11%.
Upward momentum peaks at $3.06 for Nektar Therapeutics
After closing the previous trading day at $2.83, Nektar Therapeutics is up to $3.06, which makes for a move of 8.04%/22.75 cents today. Nektar Therapeutics's market cap currently stands at $574.67 million with an average daily volume of 1.54 million shares.
Nektar Therapeutics is trading in a $2.84 – $3.06 range prior to its earnings announcement.
Charles River | -13.46% in mid-session
While on a 3 day slump, falling a total of 17.09%, Similar trend today: Charles River is down to $210.81, after ending yesterday at $243.6. Overall, a 13.46% loss or $32.79 today.
Charles River is scheduled to announce earnings results today. The consensus EPS estimate is 2.75 and the consensus revenue estimate is $1 billion.